Cargando…

A multi-factorial analysis of response to warfarin in a UK prospective cohort

BACKGROUND: Warfarin is the most widely used oral anticoagulant worldwide, but it has a narrow therapeutic index which necessitates constant monitoring of anticoagulation response. Previous genome-wide studies have focused on identifying factors explaining variance in stable dose, but have not explo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourgeois, Stephane, Jorgensen, Andrea, Zhang, Eunice J., Hanson, Anita, Gillman, Matthew S., Bumpstead, Suzannah, Toh, Cheng Hock, Williamson, Paula, Daly, Ann K., Kamali, Farhad, Deloukas, Panos, Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702374/ https://www.ncbi.nlm.nih.gov/pubmed/26739746 http://dx.doi.org/10.1186/s13073-015-0255-y

Ejemplares similares

Association of warfarin dose with genes involved in its action and metabolism
por: Wadelius, Mia, et al.
Publicado: (2006)

Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study
por: Jorgensen, Andrea L., et al.
Publicado: (2019)

Warfarin dosing algorithms: A systematic review
por: Asiimwe, Innocent G., et al.
Publicado: (2020)

Effect of Genetic Variability in the CYP4F2, CYP4F11, and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response
por: Zhang, J. E., et al.
Publicado: (2017)

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population
por: Carr, Daniel, et al.
Publicado: (2014)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

A Review of A Priori Regression Models for Warfarin Maintenance Dose Prediction
por: Francis, Ben, et al.
Publicado: (2014)

Warfarin: The End or the End of One Size Fits All Therapy?
por: Pirmohamed, Munir
Publicado: (2018)

Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
por: Bourgeois, Stephane, et al.
Publicado: (2021)

Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis
por: Jorgensen, Andrea L., et al.
Publicado: (2012)

A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa
por: Semakula, Jerome Roy, et al.
Publicado: (2020)

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
por: Pink, Joshua, et al.
Publicado: (2011)

Direct oral anticoagulants versus warfarin: is new always better than the old?
por: Burn, John, et al.
Publicado: (2018)

Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
por: Gottlieb, Assaf, et al.
Publicado: (2017)

Pharmacogenetics of warfarin in a paediatric population: Time in therapeutic range, initial and stable dosing, and adverse effects
por: Hawcutt, Daniel B, et al.
Publicado: (2014)

Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation
por: Pink, Joshua, et al.
Publicado: (2013)

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study
por: Jorgensen, Andrea L, et al.
Publicado: (2023)

Associations between occupation and heavy alcohol consumption in UK adults aged 40–69 years: a cross-sectional study using the UK Biobank
por: Thompson, Andrew, et al.
Publicado: (2021)

Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures
por: Kampouraki, Emmanouela, et al.
Publicado: (2019)

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
por: Takeuchi, Fumihiko, et al.
Publicado: (2009)

Characterizing variability in warfarin dose requirements in children using modelling and simulation
por: Hamberg, Anna-Karin, et al.
Publicado: (2014)

Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink
por: Carr, Daniel F., et al.
Publicado: (2019)

Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome
por: Turner, Richard M., et al.
Publicado: (2017)

Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials
por: Johnson, Danielle, et al.
Publicado: (2019)

Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011
por: Thomas, Kyla H, et al.
Publicado: (2014)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
por: Ho, Brian, et al.
Publicado: (2023)

Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study
por: Thompson, Andrew, et al.
Publicado: (2017)

UK veterinary professionals’ perceptions and experiences of adverse drug reaction reporting
por: Davies, Heather, et al.
Publicado: (2022)

Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study
por: Mitchell, Anneka, et al.
Publicado: (2021)

A price comparison of recently launched proprietary pharmaceuticals in the UK and the US
por: Jørgensen, Jesper, et al.
Publicado: (2016)

Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)

No Evidence in a Large UK Collection for Celiac Disease Risk Variants Reported by a Spanish Study
por: Hunt, Karen A., et al.
Publicado: (2008)

Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK
por: Thompson, Andrew, et al.
Publicado: (2018)

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
por: Clay, Emilie, et al.
Publicado: (2018)

Epidemiology of alcohol dependence in UK primary care: Results from a large observational study using the Clinical Practice Research Datalink
por: Thompson, Andrew, et al.
Publicado: (2017)

Spontaneous, Loculated, and Massive Hemothorax: An Uncommon Complication of Warfarin Therapy
por: Al-Obaidi, Ammar, et al.
Publicado: (2021)

Pathway analysis of genome-wide data improves warfarin dose prediction
por: Daneshjou, Roxana, et al.
Publicado: (2013)

Association of GGCX gene polymorphism with warfarin dose in atrial fibrillation population in Xinjiang
por: Kamali, Xiayizha, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jdpnnipp4quafg3ofa6msgd2e7